Insider Trends: Insider Purchase of OPKO Health Stock Continues 90-Day Positive Trend
07:27 AM EDT, 05/10/2021 (MT Newswires) -- On May 07, 2021, Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, reported a purchase of 75,000 shares in OPKO Health (OPK) for $287,743. Dr Frost has control over 225,492,822 company shares of which 3,068,951 shares are controlled directly and 222,423,871 shares indirectly subsequent to the transactions disclosed in the SEC Form 4 filing. These holdings have an approximate market value of $857 million as of the prior-day closing price.
In the 90 days prior to the date of this filing, there have been 2 insider transactions from the activity of one insider all of which have been purchases and resulted in the acquisition of 325,000 company shares. Relative to the preceding 90-day window of time, there were 2 transactions from 2 insiders which resulted in the net acquisition of 360,000 shares.
This is lower than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 64.3 transactions per company, and disposition of 7,246 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919121031114/xslF345X03/doc4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.